Immunovant-α (Immuvance)
Product detail for Immunovant-α, INN: immunovant alfa. Therapeutic area: Immunology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-005
INN
immunovant alfa
Therapeutic Area
Immunology
Status
Approved
Owner
Marcus Webb
Created
2022-12-13
Last Updated
2023-08-09
Markets
9
Presentations
| Form | Strength | Route |
|---|---|---|
| Film-coated tablet | 100 mg/mL | Topical |
| Inhalation powder | 0.5 mg | Intravenous |
| Oral solution | 400 mg | Intravenous |
| Film-coated tablet | 10 mg/mL | Topical |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-009 | Raredimab | raredimab | 93875-30-1 | biologic | Active |
| SUB-036 | Sodium chloride | sodium chloride | 56118-92-4 | combination | Pending |
Applications (4)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| ANVISA-2020-0005 | Brazil | Type IB Variation | Active | Sarah Chen | 2024-02-05 |
| ANMAT-2020-0035 | Brazil | MAA | Active | Dmitri Volkov | 2023-11-14 |
| ANVISA-2020-0065 | Brazil | sNDA | Completed | Dmitri Volkov | 2022-07-11 |
| ANMAT-2020-0095 | Brazil | MAA | Submitted | Dmitri Volkov | 2022-08-07 |
Markets (9)